CLIO Q1 Consolidated Net Profit Up 153% YoY to 6.7B Won... Issued Exchangeable Bonds, Achieved ESG AA Rating


  • Q1 2026 consolidated revenue 78.3B won ( -4.8% YoY), operating profit 5.8B won (Q1 2025 not disclosed), net profit 6.7B won (+153% YoY)
  • Issued 84.2B won in 2nd unregistered private exchangeable bonds on Jan 6, 2026 (exchangeable into 546,730 treasury shares at 15,406 won, maturity 2031)
  • 2025 fiscal year dividend of 250 won per share (total 4.4B won) paid in April 2026
  • Achieved highest ESG AA rating from Sustinbest (Nov 2025)
  • Ongoing lawsuits: KB Securities (4B won claim), Wemakeprice (55M won), Interpark Commerce (34M won) for unsettled payments
  • Debt ratio 36.33% (FY-end 2025: 24.24%), net debt ratio -52.92% (cash 129.3B won)
  • Sensitivity: 10% USD appreciation increases after-tax profit by 1.75B won; 10% JPY appreciation by 1.07B won
  • R&D expenditure 1.03B won (1.31% of revenue)
  • Largest shareholder CEO Han Hyun-ok holds 48.57%
  • Consolidates 4 subsidiaries (CLIO Shanghai, CLIO Lifecare, CLIO Japan, Kiwami)

KOSDAQ Filing Information


  • Filing: Quarterly Report (2026.03)
  • Company: CLIO Cosmetics (237880)
  • Submission: CLIO Cosmetics Co., Ltd
  • Receipt: 05-13-2026